Skip to content
‹ Back to IndustriesSciences

To Create a Private Market Do Governments Need To Kickstart Space Programs?

Bhavya Lal, Associate Administrator for Technology, Policy, and Strategy at NASA, joined Hosts Charity Weeden and Chris Blackerby to discuss the transition to her role at NASA. As a former employee at the Institute for Defense Analysis and the Science and Technology Institute, Lal switched from research to management. “I’m really blessed with the leadership…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Chris Blackerby · · And Diversity.And Strategy at NasaAssociate Administrator for TechnologyBhavya Lal
Share

Key takeaways

01

Bhavya Lal, Associate Administrator for Technology, Policy, and Strategy at NASA, joined Hosts Charity Weeden and Chris Blackerby to discuss the transition to her role at NASA.

02

As a former employee at the Institute for Defense Analysis and the Science and Technology Institute, Lal switched from research to management.

03

“I’m really blessed with the leadership…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Bhavya Lal, Associate Administrator for Technology, Policy, and Strategy at NASA, joined Hosts Charity Weeden and Chris Blackerby to discuss the transition to her role at NASA.

As a former employee at the Institute for Defense Analysis and the Science and Technology Institute, Lal switched from research to management. “I’m really blessed with the leadership at NASA,” she said of her role.

Lal grew up in a STEM family; her father was an electrical engineer and her mother studied math. “The idea that one could be gifted was never even brought up. You did well in school because you worked hard, not because you were smart or had some advantage,” Lal said of her upbringing. “I’ve found the idea that hard work can overcome any disadvantages to be my superpower.”

Daily, Lal has 10 to 15 meetings, which makes for long hours. She works closely with the National Space Council, the Office of Science and Technology Policy, and the Federal Aviation Administration. She has found some of the hardest things in society are not technical but are policy-based and must be examined wholistically with a long-term view.

Governments and individuals or businesses are the space industry customers. However, not many individuals and businesses cannot afford services, so Lal believes the government should kickstart certain programs and then private customers will emerge. “Let’s not have this mad dash to discovering a private market that may not already exist. Let’s work to build it,” she said.

In terms of diversity, Lal emphasized the importance of the fields individuals come from. “There’s a myriad of examples of how disruptive thinking comes from the outside,” she stated. “Our innovations will come from diverse thoughts, not trying to repeat what we’ve done before.”

More in This Series

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

CB
Chris Blackerby
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Takara Bio and SPT Labtech pair SMART-Seq kits with firefly automation scripts

Takara Bio and SPT Labtech pair SMART-Seq kits with firefly automation scripts

SPT Labtech and Takara Bio USA are teaming up to offer validated, automated workflows for library preparation, pairing Takara Bio's NGS library prep chemistries with the firefly liquid handler from SPT Labtech. Two SMART-Seq kits are available for download today. Due to ship in January 2027, the SMART-Seq mRNA Long Read Extended kit is set to be the first product to launch with a workflow tuned for firefly automation.

  • 01For sequencing cores on SPT Labtech's firefly, Takara Bio says automated workflows will be built into new kits from the start, which suggests more of the method-building could happen at the vendors before the box reaches the bench.
  • 02Whether DNA-seq and immune profiling kits arrive with firefly scripts on their launch dates will show if this becomes standard practice or stays an RNA-seq offering.

Nov 3, 2026

Crown Bioscience Appoints Guy Sheets as Senior Vice President, Commercial

Crown Bioscience appointed Guy Sheets as Senior Vice President, Commercial, bringing over 30 years of pharma and life sciences experience to lead the CRO's global commercial strategy. Sheets previously held senior commercial roles at QPS Holdings, CenExel, SGS Health Sciences, Lonza, and Thermo Fisher Scientific.

  • 01Guy Sheets brings 30+ years of commercial leadership across pharma, biotech, and life sciences, most recently as VP, Head of Global Business Development at QPS Holdings
  • 02Crown Bioscience operates 9 facilities across the US, Europe, and APAC with a portfolio of 2,800+ patient-derived xenograft models and 1,000+ tumor organoid models across 35 cancer indications
  • 03Sheets will lead Crown Bioscience’s global commercial strategy to drive growth, expand market presence, and strengthen client partnerships

Nov 3, 2026

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck has invested more than €300 million in a new bioprocessing production center in Daejeon, South Korea. It is the largest life science investment Merck has made in the region to date. The 44,500-square-meter facility makes cell culture media, process liquids and sterile sampling products to support biologics manufacturing from development through commercial supply.

  • 01A single Asia-Pacific site now supplies both small custom pre-GMP media and commercial-scale media, so a regional biologics program could scale without switching to a source outside the region.
  • 02Daejeon supplies cell culture media, process liquids, ready-to-use cleaning-in-place solutions and sterile sampling products.
  • 03The useful supplier question has moved past whether Merck has an Asia-Pacific plant: ask which product lines ship from Daejeon and what batch traceability data customers can see.

Nov 3, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

CB
Chris Blackerby

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512